Factors influencing research drug trials in adolescents with anorexia nervosa

Eating Disorders

Volumn 18, Issue 3, 2010, Pages 210-217

  Norris, Mark L ^a   Spettigue, Wendy ^a   Buchholz, Annick ^b   Henderson, Katherine A ^b   Obeid, Nicole ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ADOLESCENT; ADOLESCENT DISEASE; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG RESEARCH; FEAR; HUMAN; PATIENT ASSESSMENT; PATIENT CARE PLANNING; PATIENT IDENTIFICATION; PATIENT PARTICIPATION; PATIENT SELECTION; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT REFUSAL;

ADOLESCENT; ANOREXIA NERVOSA; BENZODIAZEPINES; CAREGIVERS; ELIGIBILITY DETERMINATION; HUMANS; ONTARIO; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS;

EID: 77951688744     PISSN: 10640266     EISSN: 1532530X     Source Type: Journal    
DOI: 10.1080/10640261003719468     Document Type: Article

References (15)

1. Agras, W. S., Brandt, H. A., Bulik, C. M., Dolan-Sewell, R., Fairburn, C. G., Halmi, K. A. et al. (2004). Report of the National Institutes of Health workshop on overcoming barriers to treatment research in anorexia nervosa. International Journal of Eating Disorders, 35, 509-521.
2. Anderluh, M., Tchanturia, K., Rabe-Hesketh, S., Collier, D., & Treasure, J. (2009). Lifetime course of eating disorders: Design and validity testing of a new strategy to define the eating disorders phenotype. Psychological Medicine, 39, 105-114.
3. Bravender, T., Bryant-Waugh, R., Herzog, D., Katzman, D., Kreipe, R. D., Lask, B. et al. (2007). Workgroup for Classification of Eating Disorders in Children and Adolescents (WCEDCA): Classification of child and adolescent eating disturbances. International Journal of Eating Disorders, 40, S117-S122.
4. Casasnovas, C., Fernandez-Aranda, F., Granero, R., Krug, I., Jimenez-Murcia, S., Bulik, C. M., et al. (2007). Motivation to change in eating disorders: Clinical and therapeutic implications. European Eating Disorder Review, 15, 449-456.
5. Chavez, M., & Insel, T. R. (2007). Eating disorders: National Institute of Mental Health's perspective. American Psychologist, 62, 159-166.
6. Gowers, S., Norton, K., Yeldham, B., Boyer, C., Levett, G., Heavey, A. et al. (1989). The St. George's prospective treatment study of anorexia nervosa: A discussion of methodological problems. International Journal of Eating Disorders, 8, 445-454.
7. Hewell, K., Hoste, R. R., & le Grange, D. (2006). Recruitment for an adolescent bulimia nervosa treatment study. International Journal of Eating Disorders, 39, 594-597.
8. Kantrowitz, J. T., & Citrome, L. (2008). Olanzapine: Review of safety 2008. Expert Opinion Drug and Safety, 7, 761-769.
9. McDermott, C., Agras, W. S., Crow, S., Halmi, K. A., Mitchell, J. E., & Bryson, S. (2004). Participant recruitment for an anorexia nervosa treatment study. International Journal of Eating Disorders, 35, 33-41.
10. Norris, M., Spettigue, W., Buchholz, A., & Henderson, K. A. (2007). Challenges associated with controlled psychopharmacological research trials in adolescents with eating disorders. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 16, 167-172.
11. Papadopoulos, F. C., Ekbom, A., Brandt, L., & Ekselius, L. (2009). Excess mortality, causes of death and prognostic factors in anorexia nervosa. British Journal of Psychiatry, 194, 10-17.
12. Spettigue, W., Buchholz, A., Henderson, K., Feder, S., Moher, D., Kourad, K., et al. (2008). Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, doubleblind, placebo-controlled trial. BMC Pediatrics, 8, 4.
13. Steinhausen, H. C. (2009). Outcomes of eating disorders. Child and Adolescent Psychiatric Clinics of North America, 18, 225-242.
14. Tschoner, A., Engl, J., Rettenbacher, M., Edlinger, M., Kaser, S., Tatarczyk, T. et al. (2009). Effects of six second generation antipsychotics on body weight and metabolism-Risk assessment and results from a prospective study. Pharmacopsychiatry, 42, 29-34.
15. Wonderlich, S. A., Crosby, R. D., Mitchell, J. E., & Engel, S. G. (2007). Testing the validity of eating disorder diagnoses. International Journal of Eating Disorders, 40, S40-S45.